Business Context and Reporting Period
This Form 6-K filing by EUDA Health Holdings Ltd covers the month of July 2024, specifically dated July 3, 2024. The filing reports on a Share Surrender Deed executed on July 1, 2024, related to the acquisition of CK Health Plus Sdn Bhd ("CK Health").
Key Financial Metrics
The filing does not provide standard financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a corporate transaction adjustment.
- Transaction Value: $15.0 million (aggregate consideration for the acquisition of CK Health).
- Original Share Issuance: 10,000,000 restricted ordinary shares valued at $1.50 per share.
- Adjusted Share Issuance: 8,571,428 shares based on a closing bid price of $1.75 per share on May 7, 2024.
- Surrendered Shares: 1,428,572 shares to be cancelled.
Material Changes
The primary material change is the reduction in the number of consideration shares issued to sellers for the CK Health acquisition. Originally, the agreement stipulated 10,000,000 shares. Due to the share price increasing to $1.75 per share immediately prior to closing, the parties agreed to issue only 8,571,428 shares to maintain the $15.0 million valuation. Consequently, the sellers surrendered 1,428,572 shares back to the company for cancellation.
Guidance, Outlook, and Risks
Resale Registration: The Company has agreed to file a Resale Registration Statement with the SEC for the consideration shares. This filing is required to be made as soon as practicable, but no later than 30 days following the completion and delivery of CK Health's audited financial statements.
Restrictions: None of the consideration shares are currently registered under the Securities Act of 1933 and cannot be offered or sold in the U.S. absent registration or an exemption.
Unusual Items: The filing details a post-agreement adjustment to share count based on market price fluctuations prior to closing, resulting in a share surrender and cancellation.
Investor Verification Checklist
- Verify the final count of outstanding shares after the cancellation of the 1,428,572 surrendered shares.
- Monitor the filing of the Resale Registration Statement, noting the 30-day deadline tied to CK Health's audited financial statements.
- Confirm the status of the audited financial statements for CK Health to determine the timeline for the resale registration.
- Review the attached Share Surrender Deed (Exhibit 10.1) for specific terms regarding the cancellation process.